[HTML][HTML] Bench-top comparison of physical properties of 4 commercially-available self-expanding intracranial stents

S Cho, W Jo, Y Jo, KH Yang, JC Park, DH Lee - Neurointervention, 2017 - ncbi.nlm.nih.gov
Purpose To better understand the performance of four commercially available neurovascular
stents in intracranial aneurysm embolization, the stents were compared in terms of their …

Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and/or chemotherapy in stage III and IV maxillary sinus cancer …

JH Kang, SH Cho, JP Kim, KM Kang, KS Cho… - Journal of Oral and …, 2012 - Elsevier
PURPOSE: The incidence of maxillary sinus cancer (MSC) is extremely rare, representing
less than 1% of all cancers. Because of its rarity, the management of locally advanced MSC …

Metabolic response evaluated by 18F-FDG PET/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for …

SH Moon, SH Cho, LC Park, JH Ji, JM Sun… - European journal of …, 2013 - Springer
Purpose Among patients with advanced non-small cell lung cancer (NSCLC), identification
of a subgroup of patients for immediate maintenance treatment after first-line chemotherapy …

Nutrition knowledge, dietary attitudes, dietary habits and awareness of food-nutrition labelling by girl's high school students

SH Cho, HH Yu - Korean Journal of Community Nutrition, 2007 - koreascience.kr
This study was carried out to investigate the nutrition knowledge, dietary attitudes, and
dietary habits of girl's high school students in Kunsan, and to investigate their recognition of …

The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma.

S Park, SH Moon, LC Park, DW Hwang… - American journal of …, 2012 - europepmc.org
Taking a step forward from the IPI, attention is focused on the role of 18F-FDG PET/CT as a
tool for guidance in risk stratification in patients with aggressive non-Hodgkin's lymphoma …

A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer

SY Oh, HC Kwon, SH Jeong, YT Joo, YJ Lee… - Investigational new …, 2012 - Springer
Background Palliative chemotherapy has been shown to have a survival benefit for patients
with recurrent or metastatic gastric cancer. 5-fluorouracil (5-FU) and cisplatin have been …

[HTML][HTML] l-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia

KS Jung, SH Cho, SJ Kim, YH Ko, ES Kang… - Journal of Hematology & …, 2016 - Springer
Aggressive nature killer cell leukemia (ANKL) is a mature NK-T cell lymphoma with worse
prognosis, but optimal treatment is unclear. Therefore, we analyzed the efficacy of l …

Comparison of 7-day azacitidine and 5-day decitabine for treating myelodysplastic syndrome

JH Lee, Y Choi, SD Kim, DY Kim, JH Lee, KH Lee… - Annals of …, 2013 - Springer
Two DNA methyltransferase inhibitors, azacitidine and decitabine, are currently approved for
the treatment of myelodysplastic syndrome (MDS). Choosing between these drugs is an …

A phase II study of irinotecan, continuous 5-fluorouracil, and leucovorin (FOLFIRI) combination chemotherapy for patients with recurrent or metastatic gastric cancer …

SH Kim, GW Lee, S il Go, SH Cho, HJ Kim… - American Journal of …, 2010 - journals.lww.com
Objectives: A phase II study was carried out to assess the efficacy and toxicity of combination
chemotherapy with irinotecan, 5-fluorouracil (5-FU), and leucovorin (FOLFIRI) for the …

Clinical features and treatment outcome of Epstein–Barr virus-positive nodal T-cell lymphoma

KS Jung, SH Cho, SJ Kim, YH Ko, WS Kim - International journal of …, 2016 - Springer
The classification of mature NK-/T-cell lymphoma mainly originating from the T-cell lineage
with predominantly nodal involvement and Epstein–Barr virus (EBV) positivity in a majority of …